David Tarrago
Overview
Explore the profile of David Tarrago including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
322
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Launes C, Camacho J, Pons-Espinal M, Lopez-Labrador F, Esteva C, Cabrerizo M, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Mar;
43(5):863-873.
PMID: 38438704
Purpose: Investigation of undiagnosed cases of infectious neurological diseases, especially in the paediatric population, remains a challenge. This study aimed to enhance understanding of viruses in CSF from children with...
2.
Guillen-Calvo L, Negredo A, Sanchez-Mora P, Molero P, Vazquez A, Cabrerizo M, et al.
J Med Virol
. 2024 Jan;
96(1):e29371.
PMID: 38235533
No abstract available.
3.
Castellot A, Camacho J, Fernandez-Garcia M, Tarrago D
PLoS One
. 2023 Dec;
18(12):e0296036.
PMID: 38127927
Introduction: Meningoencephalitis in children poses a diagnostic challenge, as etiology remains unknown for most of patients. Viral metagenomics by shotgun sequencing represents a powerful tool for investigating unknown viral infections...
4.
Camacho J, Negredo A, Carrilero B, Segovia M, Moreno A, Pozo F, et al.
Infect Dis Ther
. 2023 Oct;
12(11):2621-2630.
PMID: 37870692
Introduction: We report the case of a fatal hemorrhagic varicella primary infection in an immunocompetent man and whole-genome characterization of the virus for the investigation of biomarkers of virulence. Case:...
5.
Recio V, Gonzalez I, Tarrago D
Virol J
. 2023 Jul;
20(1):153.
PMID: 37464399
Resistant CMV infections are challenging complications after SOT and HSCT. Prompt recognition of ARMs is imperative for appropriate therapy. 108 plasma samples from 96 CMV + transplant recipients with suspected...
6.
Gomez I, Perez-Vazquez M, Tarrago D
PLoS One
. 2022 Oct;
17(10):e0274058.
PMID: 36282878
Background: Since human herpesvirus 8 (HHV-8) infection may be underestimated and HHV-8 subtype circulation in Spain remains unknown, a molecular epidemiologic study is highly desirable. Objectives: This study aimed to...
7.
Tarrago D, Gonzalez I, Gonzalez-Escribano M
BMC Genomics
. 2022 Jun;
23(1):455.
PMID: 35725386
Background: Congenital cytomegalovirus immunopathogenesis is largely unknown and multifactorial due to the complex interactions between viral, maternal, placental, and child factors. Polymorphisms in the HLA-E binding UL40 peptide mimics HLA-E...
8.
Gonzalez I, Molina-Ortega A, Perez-Romero P, Echevarria J, He L, Tarrago D
J Clin Virol
. 2018 Dec;
110:17-21.
PMID: 30517902
Background: Despite childhood universal VZV immunization was introduced in 2015, there are no data on VZV clade distribution in Spain. Objectives: To characterize the varicella-zoster virus strains circulating in Spain...
9.
Parra M, Alcala A, Amoros C, Baeza A, Galiana A, Tarrago D, et al.
Virol J
. 2017 May;
14(1):97.
PMID: 28545483
Background: Primary Human herpesvirus-7 (HHV-7) infection usually occurs during childhood and causes several clinical manifestations: mainly exanthem subitum (roseola infantum), followed by a lifelong latent state with possible reactivation in...
10.
Cabrerizo M, Diaz-Cerio M, Munoz-Almagro C, Rabella N, Tarrago D, Romero M, et al.
J Med Virol
. 2016 Aug;
89(3):435-442.
PMID: 27505281
The epidemiology and clinical association of enterovirus (EV) and parechovirus (HPeV) infections, as well as the type-distribution-according-to-age, were determined during a 4-year study period in Spain. During 2010-2013, a total...